iLex Medical Overview
Get informed when a big investor buys or sells
+ Follow5.80%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
iLex Medical (ILX.TA) currently reports a ROE of 5.8%. That is below the sector sector average of 11.64%. Use the charts on this page to explore iLex Medical's ROE history and peer comparisons.
iLex Medical's ROE of 5.8% is lower than the its sector sector average of 11.64%. That is roughly 50.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but iLex Medical's current 5.8% should be judged against industry norms (sector average: 11.64%) and against ILX.TA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 5.8%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for iLex Medical, and consider following ILX.TA for alerts when major investors trade the stock.
